| Literature DB >> 30617944 |
Bertan Cakir1, Michael Reich1, Stefan Lang1, Anima Bühler1, Christoph Ehlken1, Bastian Grundel1, Milena Stech1, Sabine Reichl1, Andreas Stahl1, Daniel Böhringer1, Hansjürgen Agostini1, Clemens Lange2.
Abstract
INTRODUCTION: To quantify optical coherence tomography angiography (OCTA) signal changes at the level of the choriocapillaris (CC) in patients with different stages of central serous chorioretinopathy (CSC) and to explore any correlation between subretinal fluid (SRF) and retinal pigment epithelium (RPE) alterations and the OCTA CC signal.Entities:
Keywords: Central serous chorioretinopathy; Choriocapillaris; OCT angiography
Year: 2019 PMID: 30617944 PMCID: PMC6393260 DOI: 10.1007/s40123-018-0159-1
Source DB: PubMed Journal: Ophthalmol Ther
CSC classification according to Daruich et al. [4]
| CSC stage | SRF | SRF duration of current episode | RPE status |
|---|---|---|---|
| Acute | + | < 4 month | Normal RPE or RPE alterations without atrophy |
| Non-resolving | + | > 4 month | Normal RPE or RPE alterations without atrophy |
| Atrophic | + or − | NA | Widespread RPE atrophy with or without gravitational tracks |
| Inactive | – | NA | Signs of previous CSC episode with RPE alterations without atrophy |
Patient characteristics
| All CSC patients | Acute CSC ( | Non-resolving CSC ( | Atrophic CSC ( | Inactive CSC ( | Healthy controls ( | |
|---|---|---|---|---|---|---|
| Age ( | 51 (30–80) | 48 (35–80) | 51 (30–70) | 60 (57–62) | 50 (33–70) | 48 (24–79) |
| Gender (M/F) | 83/18 | 34/3 | 28/9 | 10/1 | 11/5 | 14/28 |
| VA ( | 0.71 | 0.75 | 0.71 | 0.26 | 0.97 | 0.99 |
Fig. 1Patients with active central serous chorioretinopathy (CSC) demonstrate both increased and decreased OCTA signals at the level of the choriocapillaris (CC) compared with inactive CSC and control patients. Fundus autofluorescence (FAF, top row), OCTA image of the CC and flow pseudocoloration (middle rows) and OCTA segmentation (bottom row) of control patients (a), acute CCS (b), chronic non-resolving CSC (c), chronic atrophic CSC (d), and inactive CSC (e). f–i Increased CC OCTA signals are pseudocolored in red, decreased OCTA signals in green. Box and whisker plots demonstrating the number of pixels of decreased (f, g) and increased OCTA signal (h, i) in all patients and in CSC subgroups. Each dot represents one eye. Mann-Whitney t test (f, h) and ANOVA/Bonferroni multiple comparison test (g, i). **p < 0.01, ****p < 0.0001
Fig. 2Patients with acute CSC demonstrate increased OCTA signals outside the area of subretinal fluid (SRF) and decreased OCTA signals in the area with SRF. Macular edema heatmap (a), corresponding OCTA image without (b) and with (c) pseudocoloration demonstrating areas of increased (green) and decreased flow (red), and a merged image (d) of a representative patient with acute CSC. Asterisks surround the area of increased SRF defined as > 450 µm macular thickness. e Box and whisker blot demonstrating the relative number of increased (red) and decreased flow (green) in the area with and without SRF. f Ratio of increased to decreased pixels (log) in areas with and without SRF. Each dot represents one eye (n = 15). ANOVA/Dunn post hoc test (e) and Mann-Whitney t test (f). ***p < 0.001, ****p < 0.0001
Fig. 3RPE atrophy co-localizes with areas of increased choriocapillaris (CC) OCTA signal in patients with atrophic CSC, while areas revealing RPE alterations defined by increased fundus autofluorescence exhibit a normal OCTA signal. Fundus autofluorescence (FAF) image (a), FAF OCTA CC merge (b), naive (c), and pseudocolored OCTA image (d) of a representative patient with chronic atrophic CSC. Increased CC OCTA signals are pseudocolored in red, decreased OCTA signals in green. Blue asterisks surround the area of RPE atrophy, white asterisks surround the area with RPE changes. The yellow-dotted line marks the optic nerve head. e Box and whisker plots demonstrating the relative number of increased (red) and decreased flow (green) in the area with RPE atrophy, RPE alteration, and normal RPE. f Ratio of increased to decreased pixels (log) in areas with RPE atrophy, RPE alteration, and normal RPE. Each dot represents one patient (n = 6). ANOVA/Dunn post hoc test (d, e). ***p < 0.001